Theodore Karrison to Injections, Subcutaneous
This is a "connection" page, showing publications Theodore Karrison has written about Injections, Subcutaneous.
Connection Strength
0.066
-
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis. Blood Adv. 2024 11 26; 8(22):5735-5743.
Score: 0.055
-
Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial. J Pharmacol Exp Ther. 2002 Jan; 300(1):118-23.
Score: 0.011